• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[勘误] 百里醌通过负向调节TGF-β/Smad2/3信号通路抑制前列腺癌细胞的上皮-间质转化。

[Corrigendum] Thymoquinone inhibits epithelial‑mesenchymal transition in prostate cancer cells by negatively regulating the TGF‑β/Smad2/3 signaling pathway.

作者信息

Kou Bo, Liu Wei, Zhao Wei, Duan Peng, Yang Yang, Yi Qiuyue, Guo Fengwei, Li Jianpeng, Zhou Jinsong, Kou Qingshan

机构信息

Department of Cadiovascular Surgery, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.

Department of Urology, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.

出版信息

Oncol Rep. 2023 Mar;49(3). doi: 10.3892/or.2023.8491. Epub 2023 Feb 3.

DOI:10.3892/or.2023.8491
PMID:36734273
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9926509/
Abstract

After the publication of the article, an interested reader drew to the authors' attention that the Du145 'Control' migration panel in Fig. 2C appeared to overlap with the Du145 'Control' invasion panel in Fig. 5A; furthermore, two of the Du145 panels in Fig. 5A also appeared to overlap. The authors have consulted their original data, and realize that these figures were inadvertently assembled incorrectly. The corrected versions of Figs. 2 and 5, incorporating the correct data for the Du145 'Control' panel in Fig. 2C, and the TQ‑/TGF‑β OE‑ invasion and migration panels, and the TQ+/TGF‑β OE+ migration panel, in Fig. 5A, are shown on the next page. These further corrections do not grossly affect the results or the conclusions reported in this work. The authors all agree to this Corrigendum, and are grateful to the Editor of for granting them the opportunity to correct the errors that were made during the assembly of these figures. Lastly, the authors apologize to the readership for any inconvenience these errors may have caused. [Oncology Reports 38: 3592‑3598, 2017; DOI: 10.3892/or.2017.6012].

摘要

文章发表后,一位感兴趣的读者提请作者注意,图2C中的Du145“对照”迁移图似乎与图5A中的Du145“对照”侵袭图重叠;此外,图5A中的两个Du145图似乎也有重叠。作者查阅了原始数据,意识到这些图在无意中被错误拼接。下一页展示了图2和图5的校正版本,其中包含图2C中Du145“对照”图的正确数据,以及图5A中的TQ-/TGF-β OE-侵袭和迁移图,和TQ+/TGF-β OE+迁移图。这些进一步的校正不会严重影响本研究报告的结果或结论。作者们都同意这份勘误,并感谢《肿瘤学报告》的编辑给予他们机会来纠正这些图拼接过程中出现的错误。最后,作者就这些错误可能给读者带来的任何不便表示歉意。[《肿瘤学报告》38: 3592-3598, 2017; DOI: 10.3892/or.2017.6012]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e3/9926509/f68a77f323cf/or-49-03-08491-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e3/9926509/f6dc0192dce8/or-49-03-08491-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e3/9926509/f68a77f323cf/or-49-03-08491-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e3/9926509/f6dc0192dce8/or-49-03-08491-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e3/9926509/f68a77f323cf/or-49-03-08491-g01.jpg

相似文献

1
[Corrigendum] Thymoquinone inhibits epithelial‑mesenchymal transition in prostate cancer cells by negatively regulating the TGF‑β/Smad2/3 signaling pathway.[勘误] 百里醌通过负向调节TGF-β/Smad2/3信号通路抑制前列腺癌细胞的上皮-间质转化。
Oncol Rep. 2023 Mar;49(3). doi: 10.3892/or.2023.8491. Epub 2023 Feb 3.
2
[Corrigendum] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway.[勘误] Hsp90抑制剂17-AAG通过Hedgehog信号通路抑制骨肉瘤细胞的干细胞样特性和化疗耐药性。
Oncol Rep. 2023 Aug;50(2). doi: 10.3892/or.2023.8593. Epub 2023 Jun 23.
3
[Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer.[勘误] miR-382通过调控卵巢癌中的上皮-间质转化靶向ROR1来抑制迁移和侵袭。
Int J Oncol. 2024 Nov;65(5). doi: 10.3892/ijo.2024.5698. Epub 2024 Sep 27.
4
[Corrigendum] Cripto‑1 promotes epithelial‑mesenchymal transition in prostate cancer via Wnt/β‑catenin signaling.[勘误] Cripto-1通过Wnt/β-连环蛋白信号通路促进前列腺癌上皮-间质转化。
Oncol Rep. 2024 Jun;51(6). doi: 10.3892/or.2024.8734. Epub 2024 Apr 19.
5
[Corrigendum] BMI‑1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor.[勘误]BMI-1促进子宫内膜腺癌的侵袭和转移,是一个不良预后因素。
Oncol Rep. 2022 Aug;48(2). doi: 10.3892/or.2022.8352. Epub 2022 Jun 22.
6
[Corrigendum] MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1.[勘误] 微小RNA-148a通过直接靶向WNT-1抑制乳腺癌的迁移和侵袭。
Oncol Rep. 2022 Jun;47(6). doi: 10.3892/or.2022.8317. Epub 2022 Apr 13.
7
[Corrigendum] miR‑490‑5p regulates the proliferation, migration, invasion and epithelial‑mesenchymal transition of pharyngolaryngeal cancer cells by targeting mitogen‑activated protein kinase kinase kinase 9.[勘误] miR-490-5p通过靶向丝裂原活化蛋白激酶激酶激酶9调控咽喉癌细胞的增殖、迁移、侵袭及上皮-间质转化
Int J Mol Med. 2022 Jun;49(6). doi: 10.3892/ijmm.2022.5129. Epub 2022 Apr 6.
8
[Corrigendum] P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT‑related genes Snail and E‑cadherin.[勘误] P2Y2受体通过EMT相关基因Snail和E-钙黏蛋白促进乳腺癌细胞的迁移和侵袭。
Oncol Rep. 2024 Sep;52(3). doi: 10.3892/or.2024.8770. Epub 2024 Jul 4.
9
[Corrigendum] Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial‑mesenchymal transition via the AKT/GSK‑3β/Snail signaling pathway.[勘误] 白藜芦醇通过AKT/GSK-3β/Snail信号通路逆转上皮-间质转化来抑制结肠癌的侵袭和转移。
Mol Med Rep. 2022 Dec;26(6). doi: 10.3892/mmr.2022.12870. Epub 2022 Oct 12.
10
[Corrigendum] Induction of microRNA‑let‑7a inhibits lung adeno-carcinoma cell growth by regulating cyclin D1.
Oncol Rep. 2024 May;51(5). doi: 10.3892/or.2024.8721. Epub 2024 Mar 8.